Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system. Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218. We report herein a new set of small-molecule FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop
C3d is a hallmark protein of the complement system, whose presence is critical to measure the progre...
. These authors contributed equally to this work. Peptides are attracting increasing interest as pro...
Antibodies targeting the PD-1/PD-L1 immune checkpoint achieved spectacular success in anticancer the...
Complement Factor D (FD), a highly specific S1 serine protease, plays a central role in the amplific...
Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplific...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a key component of the innate immune system, recognizing pathogens and promoting their...
Chronic dysregulation of alternative complement pathway activation has been associated with diverse ...
AbstractBackground: Involved or implicated in a wide spectrum of diseases, trypsin-like serine prote...
Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has provided unprecedente...
Factor I (FI) is a serine protease that inhibits all complement pathways by degrading activated comp...
Proteolysis Targeting Chimeras (PROTACs), heterobifunctional compounds that consist of protein-targe...
C3d is a hallmark protein of the complement system, whose presence is critical to measure the progre...
. These authors contributed equally to this work. Peptides are attracting increasing interest as pro...
Antibodies targeting the PD-1/PD-L1 immune checkpoint achieved spectacular success in anticancer the...
Complement Factor D (FD), a highly specific S1 serine protease, plays a central role in the amplific...
Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplific...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate imm...
Complement is a key component of the innate immune system, recognizing pathogens and promoting their...
Chronic dysregulation of alternative complement pathway activation has been associated with diverse ...
AbstractBackground: Involved or implicated in a wide spectrum of diseases, trypsin-like serine prote...
Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has provided unprecedente...
Factor I (FI) is a serine protease that inhibits all complement pathways by degrading activated comp...
Proteolysis Targeting Chimeras (PROTACs), heterobifunctional compounds that consist of protein-targe...
C3d is a hallmark protein of the complement system, whose presence is critical to measure the progre...
. These authors contributed equally to this work. Peptides are attracting increasing interest as pro...
Antibodies targeting the PD-1/PD-L1 immune checkpoint achieved spectacular success in anticancer the...